Mortality trend for tumor correlated immune system in hyperendemic area of HCV infection in southern Italy: Joinpoint analysis

Hepatitis Monthly

Volumn 13, Issue 8, 2013, Pages

  Montella, Maurizio ^a   Malvezzi, Matteo ^b,c   Grimaldi, Maria ^a   Nocerino, Flavia ^a   Frigeri, Ferdinando ^a   Pinto, Antonio ^a   Giudice, Aldo ^a   Crispo, Anna ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Analysis; Hepacivirus; Lymphoma; Mortality; Non hodgkin

Indexed keywords

AGED; ARTICLE; CANCER MORTALITY; DISEASE CLASSIFICATION; FEMALE; HEPATITIS C; HODGKIN DISEASE; HUMAN; IMMUNE SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; REGRESSION ANALYSIS; STANDARDIZED MORTALITY RATIO;

EID: 84881044408     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.12725     Document Type: Article

References (14)

1. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology. 1997;26(4):1006-1011.
2. Montella M, Crispo A, Serraino D, Rezza G, Franceschi S. Is the spread of HCV in Southern Italy attributable to iatrogenic transmission through unsterile injections? Eur J Cancer Prev. 2003;12(1):85-86.
3. Montella M, Crispo A, Giudice A. HCC, diet and metabolic factors: Diet and HCC. Hepat Mon. 2011;11(3):159-162.
4. Ohsawa M, Shingu N, Miwa H, Yoshihara H, Kubo M, Tsukuma H, et al. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection. Int J Cancer. 1999;80(2):237-239.
5. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 1996;87(10):4296-4301.
6. Dammacco F, Gatti P, Sansonno D. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture. Leuk Lymphoma. 1998;31(5-6):463-476.
7. Talamini R, Montella M, Crovatto M, Dal Maso L, Crispo A, Negri E, et al. Non-Hodgkin's lymphoma and hepatitis C virus: a casecontrol study from northern and southern Italy. Int J Cancer.2004;110(3):380-385.
8. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, De Marco M, et al. HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leukemia Res.2001;25(9):775-781.
9. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 2000;288(5464):339-344.
10. Joinpoint Regression Program: National Cancer Institute 2010.
11. Arfe A, Malvezzi M, Bertuccio P, Decarli A, La Vecchia C, Negri E. Cancer mortality trend analysis in Italy, 1970-2007. Eur J Cancer Prev. 2011;20(5):364-374.
12. Montella M, Crispo A, Russo F, Ronga D, Tridente V, Tamburini M. Hepatitis C virus infection and new association with extrahepatic disease: multiple myeloma. Haematologica. 2000;85(8):883-884.
13. Dolcetti R, Boiocchi M. Cellular and molecular bases of B-cell clonal expansions. Clin Exp Rheumatol. 1996;14 Suppl 14:S3-S13.
14. Lauby-Secretan B, Loomis D, Grosse Y, Ghissassi FE, Bouvard V, Benbrahim-Tallaa L, et al. Carcinogenicity of polychlorinated biphenyls and polybrominated biphenyls. Lancet Oncol.2013;14(4):287-288.